Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 477-483 , October 2009

C-Reactive Protein 1059G>C Genetic Polymorphism Influences Serum C-Reactive Protein Levels after Esophagectomy in Patients with Thoracic Esophageal Cancer

  • Satoru Motoyama, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • Corresponding Author InformationCorrespondence address: Satoru Motoyama, MD, Department of Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan, 010-8543
    • ,
  • Masatomo Miura, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Yudai Hinai, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Kiyotomi Maruyama, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Shuetsu Usami, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Toshinobu Nakatsu, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Hajime Saito, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Yoshihiro Minamiya, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Toshio Suzuki, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Jun-ichi Ogawa, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan

Received 9 January 2009 ,Revised 15 June 2009 ,Accepted 17 June 2009.

References 

  1. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117:104–111
  2. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487–48490
  3. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23:118–124
  4. Morris-Stiff G, Gomez D, Prasad KR. C-reactive protein in liver cancer surgery. Eur J Surg Oncol. 2008;34:727–729
  5. Shimada H, Nabeya Y, Okazumi S, et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2003;83:248–252
  6. Hashimoto K, Ikeda Y, Korenaga D, et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer. 2005;103:1856–1864
  7. Wolford JK, Gruber JD, Ossowski VM, et al. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab. 2003;78:136–144
  8. Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004;13:137–147
  9. Eklund C, Kivimäki M, Islam MS, et al. C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2008;196:841–848
  10. Day CP, Grove J, Daly AK, et al. Tumor necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 1998;41:430–434
  11. Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C–>A substitution at position -863) in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443–1449
  12. Kim TG, Kim HY, Lee SH, et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol. 1996;46:10–17
  13. Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;61:863–866
  14. Shu XO, Gao YT, Cai Q, et al. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res. 2004;64:836–839
  15. Graziano F, Ruzzo A, Santini D, et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol. 2005;23:2339–2345
  16. Lehtimäki T, Laaksonen R, Janatuinen T, et al. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics. 2003;13:633–639
  17. Graziano F, Ruzzo A, Santini D, et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol. 2005;23:2339–2345
  18. Ross OA, Curran MD, Meenagh A, et al. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev. 2003;124:199–206
  19. Noguchi E, Shibasaki M, Arinami T, et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy. 1998;28:449–453
  20. Buraczynska M, Jozwiak L, Ksiazek P, et al. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res. 2007;150:101–105
  21. Wolford JK, Colligan PB, Gruber JD, Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab. 2003;80:338–343
  22. Edwards-Smith CJ, Jonsson JR, Purdie DM, et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999;30:526–530
  23. Hall MA, McGlinn E, Coakley G, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1:219–224
  24. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein fraction of pneumococcus. J Exp Med. 1930;52:561–571
  25. Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77:64–77
  26. Lange LA, Carlson CS, Hindorff LA, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA. 2006;296:2703–2711
  27. Miller DT, Zee RY, Suk Danik J, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005;69:623–638
  28. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24:5216–5222
  29. Wen W, Cai Q, Xiang YB, et al. The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer. 2008;112:2409–2416
  30. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol. 1995;155:2557–2563
  31. Mold C, Rodic-Polic B, Du Clos TW. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J Immunol. 2002;168:6375–6381
  32. Szalai AJ, VanCott JL, McGhee JR, et al. Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in transgenic mice. Infect Immun. 2000;68:5652–5656
  33. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J Immunol. 2002;169:7019–7025
  34. Tilg H, Vannier E, Vachino G, et al. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of Interleukin 1 (IL-1) receptor antagonist over IL-1b synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993;178:1629–1636
  35. Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23:2063–2069
  36. Russell AI, Graham DSC, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004;13:137–147
  37. Suk HJ, Ridker PM, Cook NR, Zee RY. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis. 2005;178:139–145
  38. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162:217–219
  39. Eklund C, Lehtimaki T, Hurme M. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet. 2005;32:229–232

 Disclosure Information: Nothing to disclose.

 This work was supported, in part, by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan.

PII: S1072-7515(09)00942-9

doi: 10.1016/j.jamcollsurg.2009.06.365

Journal of the American College of Surgeons
Volume 209, Issue 4 , Pages 477-483 , October 2009

Article Tools